InToWin...thank you very much for your well researched and insightful post! Lets hope you are wrong when you speak of the might of the corporate giants resisting the new wave of immunotherapy products...but I certainly see your point!
eagle 888..."In fact the thing that raised my eyebrows most about Zytiga is that Johnston & Johnston were willing to pay US$900mill even before FDA approval for the product"
This certainly has ramifications for PRR I would think. Could get interesting when the interim results are published next year, or even when Dubai comes online ...particularly with CVac's potential to be used on multiple cancers!
PRR Price at posting:
14.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)